US Stock MarketDetailed Quotes

SVRA Savara

Watchlist
  • 3.230
  • 0.0000.00%
Close Dec 20 16:00 ET
  • 3.230
  • 0.0000.00%
Post 16:09 ET
554.33MMarket Cap-7.51P/E (TTM)

About Savara Company

Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in December 1995 and is headquartered in Langhorne, PA.

Company Profile

SymbolSVRA
Company NameSavara
Listing DateApr 29, 2004
Founded1995
CEOMr. Matthew Pauls, J.D.,M.B.A.
MarketNASDAQ
Employees37
Fiscal Year Ends12-31
AddressOne Summit Square,1717 Langhorne Newtown Road,Suite 300
CityLanghorne
ProvincePennsylvania
CountryUnited States of America
Zip Code19047
Phone1-512-614-1848
Websitehttp://www.savarapharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Matthew Pauls, J.D.,M.B.A.
  • Chairman of the Board and Chief Executive Officer
  • 3.76M
  • Robert Lutz
  • Chief Operating Officer
  • 2.66M
  • David L. Lowrance
  • Chief Accounting Officer, Chief Financial and Administrative Officer
  • 1.52M
  • Anne Erickson
  • Chief Business Officer
  • --
  • Dr. Raymond Pratt
  • Chief Medical Officer
  • --
  • Richard J. Hawkins
  • Independent Director
  • 149.13K
  • Dr. An van Es-Johansson, M.D.
  • Independent Director
  • 155.63K
  • Dr. Joseph S. McCracken, D.V.M.
  • Lead Independent Director
  • 155.13K
  • Nevan Charles Elam, J.D.
  • Independent Director
  • 157.63K
  • David A. Ray
  • Independent Director
  • 158.13K
Heat List
US
Overall
Symbol
Price
% Chg

No Data